News Focus
News Focus
icon url

Lima4918

11/05/19 8:33 PM

#217782 RE: kevli33 #217781

Hampel describes his work at Eisai, which is to Create “novel therapies” for “early stage of disease.”

He is NOT connecting himself to the failed, corrupt Aducanumab trial and that amyloid hypothesis.

He is going to “innovate.”

His word, “innovate”
icon url

mrplmer

11/06/19 6:57 AM

#217796 RE: kevli33 #217781

Great Hair Style.